Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Tetrabenazine 25 mg Tablets in Healthy Subjects Under Fed Conditions
NCT03702855Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Dec 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tetrabenazine in Huntington's disease (HD) (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve at 24.00 hours. Started Dec 2015; status: completed.
02
Drugs
tetrabenazine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT03702855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702855.